Pasithea Therapeutics
KTTA
KTTA
4 hedge funds and large institutions have $1.26M invested in Pasithea Therapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
KC
1
Kepos Capital
New York
|
$1.22M |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$32K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$10K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$6K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KC
1
Kepos Capital
New York
| $1.22M | 400,000 | +400,000 | New |
|
|
TSS
2
Two Sigma Securities
New York
| $32K | 10,440 | +10,440 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $10K | 3,290 | +3,290 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $6K | 1,834 | +1,834 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|